MetLife Q2 adjusted EPS $2.02, down 11% YoY; net income $698M; PFOs ex-PRT up 5%

METLIFE INC

2025-Q2 EPS reported $2.32 revenue$35,909,000,000

Adjusted earnings $1.36B ($2.02 EPS) vs $1.63B ($2.28) in 2Q24, down 16% (11% per share).
Net income $698M ($1.03 EPS) vs $912M ($1.28) in prior year, down 23%.
Adjusted PFOs ex-PRT rose 5% to $12.4B; net investment income +9% to $5.7B; variable investment income fell to $195M pre-tax.
Returned ~$900M to shareholders: $510M buybacks + $382M dividends; holding company cash $5.2B.
Asia sales +9% CC, Latin America adj earnings +15% CC, EMEA +30%; Group Benefits adj PFOs +4%.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.